Form 4 for MDT Medtronic

Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001127602-21-028352 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-11-03	2021-11-01	MDT	TEN HOEDT ROB	EVP, Pres EMEA	A - Grant	$0.00	+832	45.4K	+2%	$0
DM	2021-11-03	2021-11-01	MDT	TEN HOEDT ROB	EVP, Pres EMEA	A - Grant	$0.00	+8,750	6,670	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2021-11-01	A	A	832	$0.00	45,418	D	—	—	(F2) This balance increased by 97 shares due to exempt transactions such as dividend reinvestment.
2	Derivative	Performance Share Units	2021-11-01	A	A	2,080	$0.00	2,080	D	— · — to —	2,080 Performance Share Units	(F5) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,080 shares will be issued. The actual number of shares to be issued could range from a low of 0 shares at minimum performance to a high of 4,160 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F6) Vests on August 2, 2024.
3	Derivative	Stock Option (Right to Buy)	2021-11-01	A	A	6,670	$0.00	6,670	D	$120.23 · 2022-08-02 to 2031-08-02	6,670 Ordinary Shares	(F3) These options become exercisable at the rate of 25% of the shares granted per year beginning on the date noted.